FRACTYL HEALTH INC

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.46. Options: 1 managers hold calls ($654.0k notional), 0 hold puts (—).

Trends to Q1 2026

Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

Fell to 5% or below in the last year: 683 Capital Management, LLC (4.8%, 2026-05-15), SILVERARC CAPITAL MANAGEMENT, LLC (2.3%, 2026-05-13), Alyeska Investment Group, L.P. (5.0%, 2026-02-17), Mithril LP (4.7%, 2026-02-12), HCC Manager LLC (3.4%, 2026-02-04), MAVERICK CAPITAL LTD (3.1%, 2025-11-14)

Holders, Q1 2026